contact either child directly.
I read it twice.
Then a third time.
There was a phone number.
And beneath the signature:
Matthew Kellerman, Founder, Kellerman Therapeutics.
I looked up.
Ethan whispered:
“Is that good?”
“I don’t know yet.”
And that was the answer I should have been giving more often.
Not yes.
Not no.
Not I’ll fix it.
I don’t know yet.
We’ll check.
Together.
Then my phone rang.
David.
I answered.
“Hello?”
His voice sounded stunned.
“Have you seen the email?”
“Yes.”
“Do you know who Matthew Kellerman is?”
“No.”
A long pause.
Then David said:
“His company manufactures one of the drugs Lily is receiving.”
I went completely still.
And suddenly the fundraiser Ethan never should have handled alone had reached someone none of us expected.
Not because Ethan had saved Lily.
But because one fourteen-year-old boy had made enough noise for adults with real resources to finally look.
